Chemoinformaics analysis of Cholestan-3-one, Cyclic1,2 ethanediyl
| Molecular Weight | 430.717 | nRot | 5 |
| Heavy Atom Molecular Weight | 380.317 | nRig | 25 |
| Exact Molecular Weight | 430.381 | nRing | 5 |
| Solubility: LogS | -7.116 | nHRing | 1 |
| Solubility: LogP | 7.496 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 81 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 83.3736 |
| nHD | 0 | BPOL | 53.6324 |
| QED | 0.442 |
| Synth | 4.785 |
| Natural Product Likeliness | 1.739 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.312 |
| Pgp-sub | 0 |
| HIA | 0.001 |
| CACO-2 | -4.879 |
| MDCK | 0.000033 |
| BBB | 0.772 |
| PPB | 0.983025 |
| VDSS | 1.311 |
| FU | 0.00716314 |
| CYP1A2-inh | 0.042 |
| CYP1A2-sub | 0.441 |
| CYP2c19-inh | 0.088 |
| CYP2c19-sub | 0.932 |
| CYP2c9-inh | 0.102 |
| CYP2c9-sub | 0.298 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.153 |
| CYP3a4-inh | 0.169 |
| CYP3a4-sub | 0.399 |
| CL | 17.225 |
| T12 | 0.018 |
| hERG | 0.197 |
| Ames | 0.03 |
| ROA | 0.027 |
| SkinSen | 0.96 |
| Carcinogencity | 0.021 |
| EI | 0.012 |
| Respiratory | 0.544 |
| NR-Aromatase | 0.222 |
| Antiviral | Yes |
| Prediction | 0.555787 |